EDAP TMS S.A EBITDA Margin 2010-2024 | EDAP
Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for EDAP TMS S.A (EDAP) over the last 10 years. The current EBITDA margin for EDAP TMS S.A as of December 31, 2024 is .
| EDAP TMS S.A EBITDA Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM EBITDA | EBITDA Margin |
| 2024-12-31 | $0.07B | $-0.02B | -31.88% |
| 2024-09-30 | $0.07B | $-0.02B | -32.35% |
| 2024-06-30 | $0.07B | $-0.02B | -32.84% |
| 2024-03-31 | $0.07B | $-0.02B | -30.30% |
| 2023-12-31 | $0.07B | $-0.02B | -33.33% |
| 2023-09-30 | $0.06B | $-0.02B | -32.79% |
| 2023-06-30 | $0.06B | $-0.02B | -26.67% |
| 2023-03-31 | $0.06B | $-0.01B | -18.64% |
| 2022-12-31 | $0.06B | $0.00B | -6.90% |
| 2022-09-30 | $0.06B | $0.00B | -1.72% |
| 2022-06-30 | $0.06B | $0.00B | -1.75% |
| 2022-03-31 | $0.05B | $0.00B | -3.70% |
| 2021-12-31 | $0.05B | $0.00B | -3.92% |
| 2021-09-30 | $0.05B | $0.00B | -1.89% |
| 2021-06-30 | $0.05B | $0.00B | 1.89% |
| 2021-03-31 | $0.05B | $0.00B | 3.92% |
| 2020-12-31 | $0.05B | 0 | 0.00% |
| 2020-09-30 | $0.04B | $0.00B | -4.76% |
| 2020-06-30 | $0.04B | $0.00B | -4.76% |
| 2020-03-31 | $0.04B | $0.00B | -4.55% |
| 2019-12-31 | $0.05B | $0.00B | 1.96% |
| 2019-09-30 | $0.05B | 0 | 0.00% |
| 2019-03-31 | $0.05B | $0.00B | -2.17% |
| 2018-12-31 | $0.05B | $0.00B | -2.22% |
| 2018-09-30 | $0.04B | $0.00B | -4.76% |
| 2018-06-30 | $0.04B | $0.00B | -4.88% |
| 2018-03-31 | $0.04B | $0.00B | -2.44% |
| 2017-12-31 | $0.04B | $0.00B | -2.56% |
| 2017-09-30 | $0.04B | $0.00B | -2.56% |
| 2017-06-30 | $0.04B | 0 | 0.00% |
| 2017-03-31 | $0.04B | 0 | 0.00% |
| 2016-12-31 | $0.04B | $0.00B | 2.50% |
| 2016-09-30 | $0.04B | $0.00B | 9.76% |
| 2016-06-30 | $0.04B | $0.00B | 7.69% |
| 2016-03-31 | $0.04B | $0.00B | 7.69% |
| 2015-12-31 | $0.04B | $0.00B | 2.78% |
| 2015-09-30 | $0.03B | $0.00B | -9.68% |
| 2015-06-30 | $0.03B | $0.00B | -6.06% |
| 2015-03-31 | $0.03B | $0.00B | -12.50% |
| 2014-12-31 | $0.04B | $0.00B | -5.56% |
| 2014-09-30 | $0.04B | $0.00B | -2.56% |
| 2014-06-30 | $0.04B | $0.00B | -2.70% |
| 2014-03-31 | $0.04B | $0.00B | -2.86% |
| 2013-12-31 | $0.03B | $0.00B | -12.50% |
| 2013-09-30 | $0.03B | $0.00B | -9.09% |
| 2013-06-30 | $0.03B | $0.00B | -9.09% |
| 2013-03-31 | $0.04B | $0.00B | -5.71% |
| 2012-12-31 | $0.03B | $0.00B | -2.94% |
| 2012-09-30 | $0.03B | $0.00B | -9.38% |
| 2012-06-30 | $0.03B | $0.00B | -8.82% |
| 2012-03-31 | $0.03B | $0.00B | -12.50% |
| 2011-12-31 | $0.03B | $0.00B | -12.50% |
| 2011-09-30 | $0.03B | $0.00B | -12.12% |
| 2011-06-30 | $0.03B | $-0.01B | -16.13% |
| 2011-03-31 | $0.03B | $-0.01B | -15.15% |
| 2010-12-31 | $0.03B | $-0.01B | -18.75% |
| 2010-09-30 | $0.03B | $-0.01B | -15.15% |
| 2010-06-30 | $0.03B | $-0.01B | -18.18% |
| 2010-03-31 | $0.03B | $-0.01B | -14.71% |
| 2009-12-31 | $0.04B | $-0.01B | -14.29% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $0.067B | $0.069B |
| EDAP TMS S.A. develops, produces, markets and distributes minimally invasive medical devices, primarily for the treatment of urological diseases. They currently produce and market devices for treatment of benign prostate hyperplasia and urinary tract stones. They are also developing a third range of products for minimally invasive destruction of certain types of tumors. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Intuitive Surgical (ISRG) | United States | $197.969B | 86.71 |
| Thermo Fisher Scientific (TMO) | United States | $152.062B | 18.39 |
| Edwards Lifesciences (EW) | United States | $45.884B | 30.08 |
| Alcon (ALC) | Switzerland | $42.389B | 28.65 |
| IDEXX Laboratories (IDXX) | United States | $41.285B | 47.45 |
| DexCom (DXCM) | United States | $33.643B | 52.00 |
| IQVIA Holdings (IQV) | United States | $24.277B | 13.60 |
| STERIS (STE) | Ireland | $24.092B | 26.57 |
| Mettler-Toledo (MTD) | United States | $24.015B | 28.56 |
| Waters (WAT) | United States | $20.783B | 29.32 |
| SONOVA HOLDING (SONVY) | Switzerland | $18.675B | 0.00 |
| Hologic (HOLX) | United States | $13.854B | 15.05 |
| Sysmex ADR (SSMXY) | Japan | $10.550B | 29.93 |
| Penumbra (PEN) | United States | $10.339B | 81.15 |
| Masimo (MASI) | United States | $8.811B | 32.50 |
| Globus Medical (GMED) | United States | $8.012B | 19.09 |
| Teleflex (TFX) | United States | $5.403B | 8.92 |
| Glaukos (GKOS) | United States | $5.388B | 0.00 |
| TransMedics (TMDX) | United States | $4.300B | 93.47 |
| Integer Holdings (ITGR) | United States | $4.144B | 21.71 |
| PROCEPT BioRobotics (PRCT) | United States | $3.209B | 0.00 |
| LivaNova (LIVN) | United Kingdom | $2.358B | 14.04 |
| Veracyte (VCYT) | United States | $2.084B | 29.24 |
| Nihon Kohden (NHNKY) | Japan | $2.062B | 23.65 |
| Elekta AB (EKTAY) | Sweden | $1.996B | 17.94 |
| Alphatec Holdings (ATEC) | United States | $1.817B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $1.320B | 0.00 |
| Artivion (AORT) | United States | $1.263B | 118.32 |
| Pulse Biosciences (PLSE) | United States | $1.164B | 0.00 |
| OPKO Health (OPK) | United States | $1.079B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $0.984B | 5.23 |
| SiBone (SIBN) | United States | $0.805B | 0.00 |
| Beta Bionics (BBNX) | United States | $0.747B | 0.00 |
| IRadimed (IRMD) | United States | $0.736B | 37.34 |
| RxSight (RXST) | United States | $0.621B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.581B | 9.04 |
| Delcath Systems (DCTH) | United States | $0.565B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.549B | 12.87 |
| AxoGen (AXGN) | United States | $0.496B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.485B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.446B | 11.87 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.441B | 0.00 |
| NeuroPace (NPCE) | United States | $0.434B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.414B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.361B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.331B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.289B | 0.00 |
| Neuronetics (STIM) | United States | $0.257B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.230B | 13.92 |
| Alpha Tau Medical (DRTS) | Israel | $0.210B | 0.00 |
| 908 Devices (MASS) | United States | $0.204B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.191B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.176B | 0.00 |
| CVRx (CVRX) | United States | $0.173B | 0.00 |
| Inogen (INGN) | United States | $0.173B | 0.00 |
| LENSAR (LNSR) | United States | $0.160B | 0.00 |
| Accuray (ARAY) | United States | $0.158B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.153B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.153B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.150B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.146B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.100B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.092B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.086B | 0.00 |
| InspireMD (NSPR) | Israel | $0.078B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.078B | 47.60 |
| EnVVeno Medical (NVNO) | United States | $0.063B | 0.00 |
| Positron (POSC) | United States | $0.054B | 0.00 |
| Hyperfine (HYPR) | United States | $0.047B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.045B | 0.00 |
| Spectral AI (MDAI) | United States | $0.041B | 0.00 |
| Precision Optics (POCI) | United States | $0.033B | 0.00 |
| Envoy Medical (COCH) | United States | $0.032B | 0.00 |
| DarioHealth (DRIO) | United States | $0.032B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.025B | 0.00 | |
| Adagio Medical Holdings (ADGM) | United States | $0.017B | 0.00 |
| NexGel (NXGL) | United States | $0.017B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.013B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.011B | 0.00 |
| PAVmed (PAVM) | United States | $0.010B | 0.00 |
| Tenon Medical (TNON) | United States | $0.008B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.008B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.007B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.005B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.004B | 0.00 |
| Nuwellis (NUWE) | United States | $0.004B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.004B | 0.00 |
| Venus Concept (VERO) | Canada | $0.003B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.003B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.002B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.002B | 0.00 |
| Avinger (AVGR) | United States | $0.002B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.001B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 16.23 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |